Primary and secondary targets for phase III , that will need to be met, will be discussed , with a time frame included. Cost Jon mentioned to run a trial - 50-100 million.
Ann: Phase 2 trial shows significant improvements in Angelman, page-79
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.82 |
Change
-0.190(1.46%) |
Mkt cap ! $1.646B | |||
| Open | High | Low | Value | Volume |
| $12.80 | $12.90 | $12.69 | $3.240M | 253.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 160 | $12.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.84 | 1285 | 16 |
View Market Depth
| Last trade - 15.17pm 16/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |